PremiumThe FlySurgery Partners reaffirms FY25 revenue view $3.3B-$3.45B, consensus $3.39B Is SGRY a Buy, Before Earnings? Strong Financial Performance and Strategic Positioning Drive Buy Rating for Surgery Partners PremiumRatingsBuy Rating for Surgery Partners: Strong Revenue Growth, Strategic Developments, and Market Opportunities Surgery Partners price target lowered to $35 from $40 at Benchmark Surgery Partners Reports Strong Revenue Growth for 2024 PremiumPre-EarningsSGRY Earnings Report this Week: Is It a Buy, Ahead of Earnings? BofA moves to No Rating on Surgery Partners after Bain offer Surgery Partners says committee to review $25.75 per share buyout proposal